MCH ANALYSIS RESEARCHMain site ↗
Consumer Discretionary

Hotels, Resorts & Cruise Lines

14 companies under coverage.

Coverage

Hotels, Resorts & Cruise Lines


Equity Research

Hilton Grand Vacations Inc (HGV)

BUY. 12-month probability-weighted target $47 (+37% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

HGVEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +31.7%
Equity Research

Norwegian Cruise Line Holdings Ltd (NCLH)

BUY. 12-month probability-weighted target $20 (+27% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

NCLHEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +24.4%
Equity Research

Wyndham Hotels & Resorts Inc (WH)

BUY. 12-month probability-weighted target $113 (+53% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

WHEquity ResearchMonte Carlo
12 October 2026Rating: BUY · Fair value vs price +22.4%
Equity Research

Booking Holdings Inc (BKNG)

HOLD. 12-month probability-weighted target $174 (+9% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

BKNGEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price +12.0%
Equity Research

Travel + Leisure Co (TNL)

HOLD. 12-month probability-weighted target $71 (+14% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

TNLEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price +8.9%
Equity Research

Expedia Group Inc. (EXPE)

HOLD. 12-month probability-weighted target $268 (-2% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

EXPEEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price +6.0%
Equity Research

Carnival Corporation (CCL)

HOLD. 12-month probability-weighted target $28 (+7% vs spot). Gross Margin explains 45% of Monte Carlo outcome variance.

CCLEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -10.6%
Equity Research

Airbnb Inc (ABNB)

SELL. 12-month probability-weighted target $138 (-17% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

ABNBEquity ResearchMonte Carlo
12 October 2026Rating: SELL · Fair value vs price -11.6%
Equity Research

Royal Caribbean Cruises Ltd (RCL)

HOLD. 12-month probability-weighted target $290 (+3% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

RCLEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -12.2%
Equity Research

Marriott International Inc (MAR)

HOLD. 12-month probability-weighted target $374 (+2% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

MAREquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -15.6%
Equity Research

Choice Hotels International Inc (CHH)

HOLD. 12-month probability-weighted target $104 (-2% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

CHHEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -16.0%
Equity Research

Vail Resorts Inc (MTN)

HOLD. 12-month probability-weighted target $142 (-3% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

MTNEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -17.5%
Equity Research

Hilton Worldwide Holdings Inc (HLT)

HOLD. 12-month probability-weighted target $317 (-3% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

HLTEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -19.0%
Equity Research

Hyatt Hotels Corporation (H)

HOLD. 12-month probability-weighted target $149 (-8% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

HEquity ResearchMonte Carlo
12 October 2026Rating: HOLD · Fair value vs price -28.3%
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies